Tissue Factor Pathway Inhibitor (TFPI) Inhibitor
-
Marstacimab
0 ImagesCat. No.: HY-P99725CAS No.: 1985638-39-8Synonyms: PF-06741086Marstacimab (PF-06741086) is an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody. Marstacimab can be used for the research of hemophilia.
-
ARC19499 sodium
0 ImagesCat. No.: HY-153480APurity: 99.40%Synonyms: BAX499 sodiumARC19499 sodium is an aptamer that inhibits tissue factor pathway inhibitor (TFPI) , thereby enabling clot initiation and propagation via the extrinsic pathway. The core aptamer binds tightly and specifically to TFPI. ARC19499 sodium blocks TFPI inhibition of both factor Xa and the TF/factor VIIa complex. ARC19499 sodium corrects thrombin generation in hemophilia A and B plasma and restores clotting in FVIII-neutralized whole blood.
-
Befovacimab
0 ImagesCat. No.: HY-P99465CAS No.: 2156634-62-5Synonyms: BAY 1093884Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research.
-
ARC19499
0 ImagesCat. No.: HY-153480CAS No.: 1350667-54-7Synonyms: BAX499ARC19499 is an aptamer that inhibits tissue factor pathway inhibitor (TFPI) , thereby enabling clot initiation and propagation via the extrinsic pathway. The core aptamer binds tightly and specifically to TFPI. ARC19499 blocks TFPI inhibition of both factor Xa and the TF/factor VIIa complex. ARC19499 corrects thrombin generation in hemophilia A and B plasma and restores clotting in FVIII-neutralized whole blood.
-
MG1113A
0 ImagesCat. No.: HY-P991379MG1113A is a human monoclonal antibody (mAb) targeting TFPI. MG1113A can be used in Haemophilia research.
-
ARC19499 sodium scrambled negative control
0 ImagesCat. No.: HY-153480CARC19499 sodium scrambled negative control is the sequence scrambled negative control of ARC19499 sodium.
